Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNeurology Physician in Houston, TX
NPI: 1013133768Primary Practice Location
HOUSTON METHODIST HOSPITAL
6565 Fannin St, Houston, TX
Primary Employer
Tmh Physician Associates PLLC
houstonmethodist.org
HQ Phone
Get M.D. Olga's Phone NumberMobile
Get M.D. Olga's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2012 - 2026
MI State Medical License
2011 - 2015
American Board of Psychiatry and Neurology
Neurology
University of Tennessee
Residency • Neurology
2008 - 2011
Internship • Internal Medicine
2007 - 2008
Vitebsk State Medical University
Medical School
Until 1997
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 246 | 536 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 59 | 78 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 50 | 138 |
| 4 | J0585Injection, onabotulinumtoxina, 1 unit | 43 | 28,500 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 43 | 43 |
Authors: Waln, Olga, Ledoux, Mark S
Journal: Tremor Other Hyperkinet Mov (N Y)
'Rechargeable deep brain stimulation implantable pulse generators in movement
Authors: Waln, Olga, Jimenez-Shahed, Joohi
Journal: Neuromodulation
Publication Date: 2013-09-24
Genotype-phenotype relations for episodic ataxia genes: MDSGene systematic review.
Lead Sponsor: Jazz Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: CX-8998
Lead Sponsor: Theranexus
Intervention / Treatment: DRUG: THN102 Dosage A, DRUG: THN102 Dosage B, DRUG: THN102 Dosage C
Lead Sponsor: ACADIA Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Pimavanserin 20 mg, DRUG: Pimavanserin 34 mg
